Here’s a look at what Thrive did this week.
A cutting-edge tool called a chromosomal microarray could help make genetic testing for disabilities more accurate and help explain their causes. David Miller, MD, PhD, clinical geneticist in the Division of Genetics at Children’s Hospital Boston talked to Thrive about the findings, and what they mean for the future of genetic testing.
A study published in the latest issue of Pediatrics takes a closer look at the relation between the ingestion of certain pesticides and cases of attention deficit hyperactivity disorder in children. Children’s Hospital Boston’s Robert Wright, MD, MPH, and David Bellinger, PhD were co-authors on the study. Wright explained to Thrive readers what the study found and what it means for parents.